We are pleased to bring you the following additions and enhancements to Developer Portal features in 22R2. REST API features added in 22R2 only affect API v22.2, unless otherwise noted.
For issues fixed in a release, see the "Developer Features" category of the fixed issues list in Clinical Data Help.
Release Date: July 29, 2022
The Close Queries by ID API allows users to close queries in batches, identifying queries to close by their ID instead of their context. Users can choose to include a message, which adds a new comment to the query while closing.
Release Date: June 24, 2022
The Retrieve Subjects API now supports the following filter options:
In the first release of this API, it didn't have full filtering abilities for subject searches.
Release Date: June 3, 2022
With this release, all retrieve APIs now use pagination. Retrieve APIs in previous API versions did not all have pagination. This change ensures no issues with large returns of data via the API.
Release Date: June 3, 2022
The Retrieve Study Countries API returns a list of Study Countries for a Study.
Release Date: June 3, 2022
The Retrieve Coding Definitions API returns the definitions of coding-enabled Forms in the study design.
This is needed for users of the coding APIs so they can get the available coding forms of the study, before they then do retrieving of Code Requests.
Release Date: June 3, 2022
To assist with available study design, the Retrieve Studies API now includes all casebook versions of the study, for reference purposes. The return of data mentions casebook version at the site, subject, and other levels. This API assists with an API user knowing all possible casebook versions, instead of only the current version.
Release Date: June 3, 2022
With this release, the Retrieve Events API now returns the frozen (frozen) and locked (locked) status of the Event or the Forms in the Event.
Release Date: June 3, 2022
Due to the complexity and nature of Forms that are used in the Local Labs module, the update via API of such data is now prohibited.